Vitamin B3 and Neurodevelopment in Parkinson’s Disease
Objective: This study aimed to investigate the potential of vitamin B3 to promote the conversion of stem cells to mature central nervous system (CNS) neurons.…Intensive speech rehabilitation in degenerative ataxias improves intelligility
Objective: To test the efficacy and tolerability of intensive home based treatment for dysarthria in ataxia Background: The loss of the ability to speak is…Genotype-phenotype correlations in 104 Uzbekish families with Spinocerebellar ataxias
Objective: Spinocerebellar ataxias are neurodegenerative disorders involving the cerebellum and its connections. There are more than 30 distinct subtypes, 16 of which are associated with…Novel CACNA1A gene mutation in a Taiwan family with episodic ataxia type 2
Objective: To illustrate a family of episodic ataxia type 2 with atypical presentations and a novel mutation of CACNA1A gene Background: The episodic ataxias (EAs)…Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis
Objective: To examine the relationship between objective markers of speech motor control, disease severity and ataxia. Background: Mild dysarthria is a common symptom of Multiple…Spinocerebellar Ataxia Type 2 Presenting with Chorea: Korean Cases
Objective: To report cases of SCA2 presenting with chorea, which have not been reported in Korea Background: Spinocerebellar ataxias (SCAs) manifest ethnic and geographical differences…DBS neuromodulation reduces severe dystonic pain in children and young people
Objective: This review analyses the prevalence of painful dystonia in a cohort of children undergoing neuromodulation. The aim was to better understand the dystonic pain…Encephalopathy in a Japanese patient with Rapid-Onset Dystonia-Parkinsonism carrying a Novel ATP1A3 mutation
Objective: To investigate underlying pathomechanisms of DYT/PARK-ATP1A3 in Japanese patient with rapid-onset dystonia-parkinsonism (RDP). Background: Mutations in ATP1A3 would lead to development of various neurological…Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies
Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia
Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 177
- Next Page »